Loading stock data…
$0.32-0.08 (-19.31%)
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States.
Accendra Health, Inc. in the Healthcare sector is trading at $0.32 with a market capitalization of $39M. Wall Street consensus targets $1.26 (4 analysts), implying a +300.7% move over the next 12 months. The stock is currently near its 52-week low of $0.32, remaining 86.8% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 4 is oversold, raising the odds of a near-term bounce. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $613.23M↓ | $627.78M↓ | $708.97M↑ | $697.26M↑ | $681.92M |
| Gross Profit | $263.41M↓ | $278.03M↓ | $323.26M↑ | $322.20M↓ | $324.60M |
| Operating Income | $19.85M↓ | $22.80M↓ | $51.76M↓ | $56.36M↓ | $56.75M |
| Net Income | -$89.07M↓ | -$6.47M↑ | -$56.33M↑ | -$150.28M↑ | -$869.06M |
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, includi...